|
| Variables | Complications | OR (95% IC) | p-value | |
| Yes | No | ||||
| Age | ≥55 years | 13 (28.9) | 32 (71.1) | 0.54 (0.09 - 3.16) | 0.49 |
| <55 years | 5 (19.2) | 21 (80.8) | |||
| Sex | Men | 7 (16.7) | 34 (83.3) | 0.22 (0.04 - 1.12) | 0.11 |
| Women | 11 (37.9) | 18 (62.1) | |||
| Comorbidities/Risk factors | Hypertension | 4 (40) | 6 (60) | 2.19 (0.30 - 15.85) | 0.59 |
| Diabetes | 4 (66.7) | 2 (33.3) | 7.14 (0.56 - 90.80) | 0.16 | |
| Tobacco | 1 (9.1) | 10 (90.9) | - | 0.30 | |
| Alcohol | 7 (38.9) | 11 (61.1) | 3.36 (0.65 - 17.27) | 0.19 | |
| BMI | Malnourished | 1 (50) | 1 (50) | - | 0.26 |
| Normal | 2 (12.5) | 14 (87.5) | 0.34 (0.04 - 3.23) | 0.65 | |
| Overweight/Obese | 15 (28.3) | 38 (71.7) | 1.29 (0.21 - 7.76) | 1 | |
| WHO performance status | Stages 3 and 4 | 10 (31.3) | 22 (68.7) | 3.36 (0.65 - 17.27) | 0.19 |
| Stages 1 and 2 | 8 (20.5) | 31 (79.5) | |||
| ASA score | ASA > 2 | 16 (24.6) | 49 (75.4) | - | 0.01 |
| ASA ≤ 2 | 2 (33.3) | 4 (66.7) | |||
| Diagnosis | Pancreatic head cancer | 13 (23.6) | 42 (76.4) | 1.01 (0.17 - 6.46) | 1 |
| Extrahepatic cholangiocarcinoma | 3 (37.5) | 5 (62.5) | 0.96 (0.09 - 10.58) | 1 | |
| Ampullary carcinoma | 2 (33.3) | 6 (66.7) | 0.96 (0.09 - 10.58) | 1 | |
| cTNM stage | Stage I and II | 11 (31.4) | 24 (68.6) | 2.73 (0.56 - 13.37) | 0.26 |
| Stage III and IV | 7 (19.4) | 29 (80.6) | |||
| Surgical treatment | Curative | 4 (50) | 4 (50) | 3.43 (0.41 - 28.94) | 0.27 |
| Palliative | 14 (22.2) | 49 (77.8) | |||